Evidence map›Paper›PMID 32070183›Full record

ArticleAutophagy2021

The neurosteroid allopregnanolone protects retinal neurons by effects on autophagy and GABRs/GABA

Makoto Ishikawa, Sanae Takaseki, Takeshi Yoshitomi, Douglas F Covey, Charles F Zorumski, Yukitoshi Izumi

Open access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Alleviation of Tri-Toxics · 2025
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. New directions in neurosteroid therapeutics in neuropsychiatry.Neuroscience and biobehavioral reviews · 2025
    Review
  9. Review
  10. The potential role of amino acids in myopia: inspiration from metabolomics.Metabolomics : Official journal of the Metabolomic Society · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Neurosteroid enantiomers as potentially novel neurotherapeutics.Neuroscience and biobehavioral reviews · 2023
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Makoto IshikawaDepartment of Ophthalmology, Akita University Graduate School of Medicine, Akita, Japan.ORCID 0000-0002-1808-1799
Sanae TakasekiDepartment of Ophthalmology, Akita University Graduate School of Medicine, Akita, Japan.
Takeshi YoshitomiDepartment of Ophthalmology, Akita University Graduate School of Medicine, Akita, Japan.ORCID 0000-0001-6529-4650
Douglas F CoveyDepartment of Developmental Biology, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-9316-8683
Charles F ZorumskiTaylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-9704-5154
Yukitoshi IzumiTaylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-5596-1031
Akita University · JPWashington University in St. Louis · US

Funding

Oxysterols and NMDAR FunctionR01MH101874 · NIMH · WASHINGTON UNIVERSITY · PI MENNERICK, STEVEN J, ZORUMSKI, CHARLES F · 2014 to 2018
$1.9M
NIMH NIH HHS R01 MH101874
6 · The paper itself

Abstract

In an

Indexed as

AnimalsApoptosisCell DeathGlaucomaIntraocular PressureNeuroprotective AgentsNeurosteroidsOptic NervePregnanoloneRatsRetinaRetinal Ganglion CellsNeuroprotective AgentsNeurosteroidsPregnanoloneAllopregnanoloneautophagyglaucomaintraocular pressureneurosteroid

Identifiers

PMID32070183
PMCPMC8032250
OpenAlexW3007948840

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.